.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Mallinckrodt
Baxter
Queensland Health
Novartis
Chubb
Federal Trade Commission
Cerilliant
Healthtrust

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202755

« Back to Dashboard
NDA 202755 describes TRANEXAMIC ACID, which is a drug marketed by Viva Hlthcare, Emcure Pharms Ltd, Zydus Pharms Usa Inc, Mylan, Akorn, Aurobindo Pharma Ltd, Acic Fine Chems, Gland Pharma Ltd, Amneal Pharms Co, Virtus Pharms, Amerigen Pharms Ltd, Mylan Institutional, X-gen Pharms Inc, Luitpold, Apotex Inc, Actavis Labs Fl Inc, and Fresenius Kabi Usa, and is included in nineteen NDAs. It is available from twenty suppliers. Additional details are available on the TRANEXAMIC ACID profile page.

The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are seven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.

Summary for 202755

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 202755

Physiological EffectDecreased Fibrinolysis

Medical Subject Heading (MeSH) Categories for 202755

Suppliers and Packaging for NDA: 202755

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION 202755 ANDA Virtus Pharmaceuticals, LLC 69543-376 69543-376-22 1 AMPULE in 1 CARTON (69543-376-22) > 10 mL in 1 AMPULE
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION 202755 ANDA Virtus Pharmaceuticals, LLC 69543-376 69543-376-23 10 AMPULE in 1 CELLO PACK (69543-376-23) > 10 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Feb 25, 2016TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Farmers Insurance
US Army
Baxter
Cantor Fitzgerald
Chinese Patent Office
QuintilesIMS
Fuji
Covington
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot